Diagnostic performance of Strongyloides-specific IgG4 detection in urine for diagnosis of human strongyloidiasis

Wongphutorn, P; Worasith, C; Kopolrat, KY; Homwong, C; Sithithaworn, J; Eamudomkarn, C; Techasen, A; Tippayawat, P; Pitaksakurat, O; Hongsrichan, N; Crellen, T; Sithithaworn, P

Journal article

Diagnostic performance of Strongyloides-specific IgG4 detection in urine for diagnosis of human strongyloidiasis

Abstract:: BACKGROUND: Detection of parasite-specific IgG in urine is a sensitive method for diagnosis of strongyloidiasis and gives similar accuracy to serum IgG. However, there are no data concerning detection of IgG subclass in urine. To further explore the utility of diagnosis from urine samples, we evaluated the diagnostic performance of IgG4 in urine compared with parasitological and other immunological methods. METHODS: The urine and sera included proven strongyloidiasis (group 1, n = 93), other parasitic infections (group 2, n = 40) and parasite negatives (group 3, n = 93). The performance of Strongyloides-specific IgG4 in urine for diagnosis of strongyloidiasis using fecal examinations as the reference standard was assessed. RESULTS: With fecal examination as a gold standard, Strongyloides-specific IgG4 in urine had 91.4% sensitivity and 93.2% specificity while serum IgG4 had 93.6% sensitivity and 91.0% specificity. IgG4 in both urine and serum had almost perfect diagnostic agreements with fecal examination (Cohen's kappa coefficient was > 0.8). Cross-reactivity to Opisthorchis viverrini and Taenia spp. of IgG4 in urine were 7.5% and 12.5% in serum. Concurrent analyses of total IgG in urine and serum showed that the sensitivities (97.9-100%) and specificities (88.7-91.0%) were similar (P > 0.05). The sensitivity for parasitological examination by the formalin-ethyl acetate concentration technique (FECT) was 49.5% and that for agar plate culture technique (APC) it was 92.6%. CONCLUSION: Our findings showed that specific IgG4 detection in urine yielded similar diagnostic performance to the same biomarkers in serum. This suggests that accurate diagnosis of strongyloidiasis can be performed using urine samples and IgG4 is a valid choice of diagnostic marker. Further assessment is required to assess the utility of urine IgG4 for measuring the response treatment in strongyloidiasis.

Publication status:: Published

Peer review status:: Peer reviewed

Actions

Email

Email this record

Send the bibliographic details of this record to your email address.

Your Email
Please enter the email address that the record information will be sent to.

-
Your message (optional)
Please add any additional information to be included within the email.
Share
Cite

Cite this record

APA Style

Wongphutorn, P., Worasith, C., Kopolrat, K. Y., Homwong, C., Sithithaworn, J., Eamudomkarn, C., Techasen, A., Tippayawat, P., Pitaksakurat, O., Hongsrichan, N., Crellen, T., & Sithithaworn, P. (2023). Diagnostic performance of Strongyloides-specific IgG4 detection in urine for diagnosis of human strongyloidiasis. Parasites & Vectors, 16(1), 298–298.

MLA Style

Wongphutorn, P, et al. “Diagnostic Performance of Strongyloides-Specific IgG4 Detection in Urine for Diagnosis of Human Strongyloidiasis.” Parasites & Vectors, vol. 16, no. 1, 2023, pp. 298–98.

Chicago Style

Wongphutorn, P, C Worasith, KY Kopolrat, et al. 2023. “Diagnostic Performance of Strongyloides-Specific IgG4 Detection in Urine for Diagnosis of Human Strongyloidiasis.” Parasites & Vectors 16 (1): 298–98.
Print